Valuation : GENFIT

Market Cap 71Cr 82Cr 66Cr 61Cr 113.83Cr 7.77TCr 114.44Cr 785.48Cr 305.73Cr 3.95TCr 307.44Cr 300.77Cr 13TCr P/E 2026 *
36.4x
P/E 2027 * 93.8x
Enterprise Value 66Cr 76Cr 62Cr 56Cr 105.59Cr 7.21TCr 106.16Cr 728.63Cr 283.6Cr 3.67TCr 285.19Cr 279.01Cr 12TCr EV / Sales 2026 *
6.54x
EV / Sales 2027 * 5.16x
Free-Float
86.89%
Yield 2026 *
-
Yield 2027 * -
1 day+1.56%
1 week+0.84%
Current month+1.41%
1 month+2.14%
3 months+68.51%
6 months+61.30%
Current year+172.36%
1 week 13.84
Extreme 13.84
14.98
1 month 12.74
Extreme 12.74
15.2
Current year 5.05
Extreme 5.05
15.48
1 year 3.05
Extreme 3.048
15.48
3 years 2.62
Extreme 2.62
15.48
5 years 2.62
Extreme 2.62
15.48
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 16/09/2019
Director of Finance/CFO 52 22/04/2021
Chief Tech/Sci/R&D Officer - 27/11/2025
Director TitleAgeSince
Chairman 70 16/06/2017
Director/Board Member 54 15/09/1999
Director/Board Member 58 16/06/2017
Date Insider Type Main position Quantity % Market Cap. Importance
05/03/26 Exercice

Chief Operating Officer

11,250 0.0225%
05/03/26 Exercice

Chief Operating Officer

7,083 0.0142%
05/03/26 Sell

Chief Operating Officer

7,083 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
+1.56%+0.84%+326.79%+341.23% 82Cr
+0.42%-1.50%+2.73%+16.90% 4.97TCr
+2.09%-0.71%+452.73%+498.77% 4.5TCr
-1.09%-0.41%+35.40%+15.17% 4.25TCr
-0.26%-4.71%+17.19%+71.67% 4.08TCr
-0.48%-0.84%+16.25%+49.80% 3.29TCr
-1.06%+2.87% - - 1.71TCr
-1.81%-5.02%+22.65%+113.24% 1.63TCr
+0.25%-1.48%+16.84%+26.26% 1.44TCr
-2.05%-5.14%+72.89%+34.69% 1.35TCr
Average -0.24%-2.33%+107.05%+129.75% 2.73TCr
Weighted average by Cap. -0.10%-2.27%+98.10%+122.91%

Financials

2026 *2027 *
Net sales 10Cr 12Cr 9.43Cr 8.59Cr 16Cr 1.1TCr 16Cr 111.42Cr 43Cr 560.77Cr 44Cr 43Cr 1.86TCr 12Cr 14Cr 12Cr 11Cr 20Cr 1.36TCr 20Cr 137.94Cr 54Cr 694.25Cr 54Cr 53Cr 2.3TCr
Net income 2.29Cr 2.65Cr 2.15Cr 1.96Cr 3.69Cr 251.71Cr 3.71Cr 25Cr 9.9Cr 128.04Cr 9.96Cr 9.74Cr 424.56Cr 68L 78.83L 63.96L 58.27L 1.1Cr 75Cr 1.1Cr 7.56Cr 2.94Cr 38Cr 2.96Cr 2.9Cr 126.19Cr
Net Debt -5.11Cr -5.93Cr -4.81Cr -4.38Cr -8.24Cr -562.41Cr -8.28Cr -57Cr -22Cr -286.09Cr -22Cr -22Cr -948.61Cr -6.62Cr -7.67Cr -6.22Cr -5.67Cr -11Cr -728.06Cr -11Cr -74Cr -29Cr -370.35Cr -29Cr -28Cr -1.23TCr
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
161
Date Price Change Volume
02/26/02 14.34 +1.56% 28,023
01/26/01 €14.12 -0.14% 1,46,344
31/26/31 €14.14 -1.67% 2,64,283
28/26/28 €14.38 -0.96% 2,94,675
27/26/27 €14.52 +2.11% 1,71,883
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
14.12EUR
Average target price
15.90EUR
Spread / Average Target
+12.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock